BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) Director Hannah Valantine sold 4,292 shares o...
BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the 13 Biotech Stocks with Huge Upside Potential. In ...
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - Equities research analysts at Cantor Fitzgerald...
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - Analysts at HC Wainwright raised their Q2 2025 ...